Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Leidos Holdings, Inc.LDOS · Entity 668 | Director | February 13, 2025 | February 14, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Leidos Holdings, Inc.
Report date February 13, 2025 · Filed February 14, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,408 |
Ending reported balance
After 2025-02-13 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-02-13 · Exercise / conversion · Acquired 3,345 · Balance 9,753 Row 2 · 2025-02-13 · Tax withholding · Disposed 1,834 · Balance 7,919 F1: Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees. Row 3 · 2025-02-13 · Sale · Disposed 1,511 · Balance 6,408 F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices from $134.51 to $134.665 inclusive. The reporting person undertakes to providing to Leidos Holdings, Inc., any security holder of Leidos Holdings, Inc., or the staff of the Securities Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the aforementioned range. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $75.02 · Expires 2026-05-09 | Direct | 0 |
Reported balance
After 2025-02-13 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-02-13 · Exercise / conversion · Disposed 3,345 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices from $134.51 to $134.665 inclusive. The reporting person undertakes to providing to Leidos Holdings, Inc., any security holder of Leidos Holdings, Inc., or the staff of the Securities Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the aforementioned range.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2025 Filed Feb 14, 2025 21:33 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,345 | $0.00 Strike: $75.02 | $0.00 |
DisclosureSEC source: 0001628280-25-005768 · wk-form4_1739568804.xml · derivative · entry 4 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,345 shares Expires 2026-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 21:33 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | SaleCommon Stock | 1,511 | $134.56 | $203,322.12 |
DisclosureSEC source: 0001628280-25-005768 · wk-form4_1739568804.xml · nonDerivative · entry 3 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,408 F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices from $134.51 to $134.665 inclusive. The reporting person undertakes to providing to Leidos Holdings, Inc., any security holder of Leidos Holdings, Inc., or the staff of the Securities Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the aforementioned range. Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 21:33 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Tax withholdingCommon Stock | 1,834 | $136.85 | $250,982.90 |
DisclosureSEC source: 0001628280-25-005768 · wk-form4_1739568804.xml · nonDerivative · entry 2 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,919 F1 · kind: Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees. Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 21:33 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionCommon Stock | 3,345 | $75.02 | $250,941.90 |
DisclosureSEC source: 0001628280-25-005768 · wk-form4_1739568804.xml · nonDerivative · entry 1 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2024 Filed Nov 1, 2024 20:30 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | SaleCommon Stock | 1,047 | $184.94 | $193,632.18 |
DisclosureSEC source: 0001628280-24-044766 · wk-form4_1730493007.xml · nonDerivative · entry 1 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,408 Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 21:09 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | SaleCommon Stock | 1,059 | $145.23 | $153,798.57 |
DisclosureSEC source: 0001628280-24-034816 · wk-form4_1722892169.xml · nonDerivative · entry 1 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,455 Read SEC document |
| May 03, 2024 Filed May 7, 2024 21:59 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantStock Option (Right to Buy) · Derivative | 1,179 | $0.00 Strike: $142.66 | $0.00 |
DisclosureSEC source: 0001628280-24-021225 · wk-form4_1715119140.xml · derivative · entry 2 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,179 Underlying: Common Stock · 1,179 shares Expires 2031-05-02 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 03, 2024 Filed May 7, 2024 21:59 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 912 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-021225 · wk-form4_1715119140.xml · nonDerivative · entry 1 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,514 Read SEC document |
| May 02, 2024 Filed May 3, 2024 20:12 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,879 | $0.00 Strike: $70.64 | $0.00 |
DisclosureSEC source: 0001628280-24-020289 · wk-form4_1714767145.xml · derivative · entry 4 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,879 shares Expires 2025-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2024 Filed May 3, 2024 20:12 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | SaleCommon Stock | 1,952 | $142.21 | $277,591.97 |
DisclosureSEC source: 0001628280-24-020289 · wk-form4_1714767145.xml · nonDerivative · entry 3 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,602 F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices from $142.20 to $142.22 inclusive. The reporting person undertakes to providing to Leidos Holdings, Inc., any security holder of Leidos Holdings, Inc., or the staff of the Securities Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the aforementioned range. Read SEC document |
| May 02, 2024 Filed May 3, 2024 20:12 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Tax withholdingCommon Stock | 1,927 | $142.19 | $274,000.13 |
DisclosureSEC source: 0001628280-24-020289 · wk-form4_1714767145.xml · nonDerivative · entry 2 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,554 F1 · kind: Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees. Read SEC document |
| May 02, 2024 Filed May 3, 2024 20:12 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionCommon Stock | 3,879 | $70.64 | $274,012.56 |
DisclosureSEC source: 0001628280-24-020289 · wk-form4_1714767145.xml · nonDerivative · entry 1 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2023 Filed May 9, 2023 23:27 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantStock Option (Right to Buy) · Derivative | 2,296 | $0.00 Strike: $79.45 | $0.00 |
DisclosureSEC source: 0001628280-23-016958 · wf-form4_168367484640741.xml · derivative · entry 2 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,296 Underlying: Common Stock · 2,296 shares Expires 2030-05-04 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 05, 2023 Filed May 9, 2023 23:27 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 1,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-016958 · wf-form4_168367484640741.xml · nonDerivative · entry 1 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,602 Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:37 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantStock Option (Right to Buy) · Derivative | 1,784 | $0.00 Strike: $104.06 | $0.00 |
DisclosureSEC source: 0001628280-22-013688 · wf-form4_165221862337646.xml · derivative · entry 2 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,784 Underlying: Common Stock · 1,784 shares Expires 2029-05-05 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:37 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 1,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-013688 · wf-form4_165221862337646.xml · nonDerivative · entry 1 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,028 Read SEC document |
| May 07, 2021 Filed May 12, 2021 00:20 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantStock Option (Right to Buy) · Derivative | 2,123 | $0.00 Strike: $103.90 | $0.00 |
DisclosureSEC source: 0001628280-21-009893 · wf-form4_162077880682413.xml · derivative · entry 2 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,123 Underlying: Common Stock · 2,123 shares Expires 2028-05-06 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 07, 2021 Filed May 12, 2021 00:20 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 1,059 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-009893 · wf-form4_162077880682413.xml · nonDerivative · entry 1 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,922 Read SEC document |
| May 08, 2020 Filed May 12, 2020 21:03 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 1,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-007587 · wf-form4_158931741647683.xml · nonDerivative · entry 1 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,863 Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:33 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantStock Option (Right to Buy) · Derivative | 3,345 | $0.00 Strike: $75.02 | $0.00 |
DisclosureSEC source: 0001225208-19-007956 · doc4.xml · derivative · entry 2 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,345 Underlying: Common Stock · 3,345 shares Expires 2026-05-09 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:33 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-007956 · doc4.xml · nonDerivative · entry 1 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,816 Read SEC document |
| August 10, 2018 Filed Aug 14, 2018 21:35 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantStock Option (Right to Buy) · Derivative | 3,879 | $0.00 Strike: $70.64 | $0.00 |
DisclosureSEC source: 0001225208-18-012557 · doc4.xml · derivative · entry 2 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,879 Underlying: Common Stock · 3,879 shares Expires 2025-08-09 F1 · derivative.exercise_date: The options shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual stockholders meeting of the Company is concluded. Read SEC document |
| August 10, 2018 Filed Aug 14, 2018 21:35 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 1,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-012557 · doc4.xml · nonDerivative · entry 1 Kovarik Robert C JR · CIK 0001512157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,416 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.